Search

Your search keyword '"Waked, Imam"' showing total 476 results

Search Constraints

Start Over You searched for: Author "Waked, Imam" Remove constraint Author: "Waked, Imam"
476 results on '"Waked, Imam"'

Search Results

4. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission update

6. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study

7. A global research priority agenda to advance public health responses to fatty liver disease

10. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

12. Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa

13. Hepatitis C Elimination in Egypt: Story of Success.

17. Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE): a phase 3 randomised controlled trial

18. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

19. Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma [Corrigendum]

20. Joint statement in support of hepatitis C human challenge studies

22. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

25. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa region

26. Efficacy and safety of Sofosbuvir Plus Daclatasvir bilayer tablet with or without Ribavirin in patients with chronic hepatitis C genotype 4 Infection

28. Progress towards elimination of viral hepatitis: a Lancet Gastroenterology & HepatologyCommission update

29. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

33. Ombitasvir, paritaprevir, and ritonavir plus ribavirin for chronic hepatitis C virus genotype 4 infection in Egyptian patients with or without compensated cirrhosis (AGATE-II): a multicentre, phase 3, partly randomised open-label trial

34. Joint statement in support of hepatitis C human challenge studies

47. Impacts of the Egyptian national screening and treatment programme for viral hepatitis C: A cost‐effectiveness model.

49. International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patients

50. Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020:a modelling study

Catalog

Books, media, physical & digital resources